More articles from Diabetes and the Kidney

Open Access
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
John P. Hanrahan, Ian H. de Boer, George L. Bakris, Phebe J. Wilson, James D. Wakefield, Jelena P. Seferovic, Jennifer G. Chickering, Yueh-tyng Chien, Kenneth Carlson, Michael D. Cressman, Mark G. Currie, G. Todd Milne and Albert T. Profy

CJASN January 2021, 16 (1) 59-69; DOI: https://doi.org/10.2215/CJN.08410520

Add to Selected Citations
You have accessRestricted Access
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
Min Zhao, Shusen Sun, Zhenguang Huang, Tiansheng Wang and Huilin Tang

CJASN January 2021, 16 (1) 70-78; DOI: https://doi.org/10.2215/CJN.11220720

Add to Selected Citations
You have accessRestricted Access
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN)
Sadayoshi Ito, Naoki Kashihara, Kenichi Shikata, Masaomi Nangaku, Takashi Wada, Yasuyuki Okuda and Tomoko Sawanobori

CJASN December 2020, 15 (12) 1715-1727; DOI: https://doi.org/10.2215/CJN.06870520

Add to Selected Citations
You have accessRestricted Access
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²
George Bakris, Megumi Oshima, Kenneth W. Mahaffey, Rajiv Agarwal, Christopher P. Cannon, George Capuano, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, Richard Oh, Carol Pollock, Norman Rosenthal, David C. Wheeler, Hong Zhang, Bernard Zinman, Meg J. Jardine and Vlado Perkovic

CJASN December 2020, 15 (12) 1705-1714; DOI: https://doi.org/10.2215/CJN.10140620

Add to Selected Citations
You have accessRestricted Access
Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD
Flory T. Muanda, Matthew A. Weir, Lavanya Bathini, Kristin K. Clemens, Vlado Perkovic, Manish M. Sood, Eric McArthur, Jessica M. Sontrop, Richard B. Kim and Amit X. Garg

CJASN December 2020, 15 (12) 1728-1739; DOI: https://doi.org/10.2215/CJN.08310520

Add to Selected Citations
Open Access
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories
Adeera Levin, Vlado Perkovic, David C. Wheeler, Stefan Hantel, Jyothis T. George, Maximilian von Eynatten, Audrey Koitka-Weber, Christoph Wanner and on behalf of the EMPA-REG OUTCOME Investigators

CJASN October 2020, 15 (10) 1433-1444; DOI: https://doi.org/10.2215/CJN.14901219

Add to Selected Citations
You have accessRestricted Access
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C.B. Tan, Ching-Lung Cheung, Alan C.H. Lee, Joanne K.Y. Lam, Ying Wong and Sammy W.M. Shiu

CJASN March 2020, 15 (3) 359-366; DOI: https://doi.org/10.2215/CJN.11710919

Add to Selected Citations
You have accessRestricted Access
Sodium Bicarbonate Supplementation and Urinary TGF-β1 in Nonacidotic Diabetic Kidney Disease
Kalani L. Raphael, Tom Greene, Guo Wei, Tristin Bullshoe, Kunani Tuttle, Alfred K. Cheung and Srinivasan Beddhu

CJASN February 2020, 15 (2) 200-208; DOI: https://doi.org/10.2215/CJN.06600619

Add to Selected Citations
Open Access
Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria
Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda and Tomoko Sawanobori

CJASN August 2019, 14 (8) 1161-1172; DOI: https://doi.org/10.2215/CJN.14751218

Add to Selected Citations
You have accessRestricted Access
Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes
Toshiaki Ohkuma, Min Jun, John Chalmers, Mark E. Cooper, Pavel Hamet, Stephen Harrap, Sophia Zoungas, Vlado Perkovic, Mark Woodward and on behalf of the ADVANCE Collaborative Group

CJASN June 2019, 14 (6) 862-872; DOI: https://doi.org/10.2215/CJN.13391118

Add to Selected Citations

Main menu

User menu

Search

More articles from Diabetes and the Kidney

Pages

Articles

Information for Authors

About

Journal Information

More Information